Statement of Consolidated Operations (USD $)	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Net Revenues:
Plastics	$ 3,139,267
Royalties - former medical device business	18,480
Total revenues	3,157,747
Cost of Sales-Plastics	(3,269,601)
Gross Profit	(111,854)
Operating Expenses:
Selling, general and administrative	1,248,508	365,641
Total Expenses	1,248,508	365,641
Operating loss	(1,360,362)	(365,641)
Other Income and (Expense):
Interest income	24,266	8,033
Miscellaneous income	7,330	2,532
Interest expense	(143,565)
Total Other Income and (Expense)	(111,969)	10,565
Net loss before income taxes	(1,472,331)	(355,076)
Net loss from continuing operations	(1,472,331)	(355,076)
Income (Loss) from discontinued operations	332,786	761,388
Loss on sale of discontinued operations	(123,702)
Net income (loss) from discontinued operations	209,084	761,388
Net income (loss)	$ (1,263,247)	$ 406,312
Earnings per share: Net Income (loss) per common share:
Basic income (loss) from continuing operations per share	$ (0.03)	$ (0.01)
Diluted income (loss) from continuing operations per share	$ (0.03)	$ (0.01)
Basic income (loss) from discontinued operations per share	$ 0.00	$ 0.02
Diluted income (loss) from discontinued operations per share	$ 0.00	$ 0.02
Basic income (loss) per common share	$ (0.03)	$ 0.01
Diluted income (loss) per common share	$ (0.03)	$ 0.01
Weighted Average Common Shares Outstanding Basic	46,817,291	42,646,016
Weighted Average Common Shares Outstanding Diluted	54,153,971	49,982,696